Abstract
The intestinal epithelium is a tissue that undergoes continuous self-renewal initiated at the bottom of the crypts, which harbor the intestinal stem cell (ISC) pool. The ISC pool is sub-divided into crypt base columnar (CBC) cells at the crypt bottom and label retention cells (LRC) at position +4 from the crypt bottom. CBC cells are marked by Leucine-rich repeat-containing G-protein coupled receptor (Lgr5) while LRC cells are identified by several markers including Bmi1, mTert, Hopx, Lrig1, and Sox9. Krüppel-like factors (KLFs) belong to a family of transcription factors that exert important physiological function in various tissues. In the intestine, KLF4 is predominantly expressed in the terminally differentiated, non-proliferating cells lining the villus. Its deletion in the adult mouse intestine results in perturbed homeostasis. In contrast, KLF5 is expressed in actively proliferating cells of the intestinal crypt, including CBC cells and transit amplifying (TA) cells. We recently investigated the effect of Klf5 deletion specifically from the Lgr5-expressing CBC cells in adult mouse intestine using an inducible Cre recombinase system. Shortly (3–5 days) after Cre induction, proliferation of both CBC and TA cells ceased, which was accompanied by an increase in apoptosis in the crypt. Beginning at two weeks following Cre induction, both Klf5 expression and proliferation re-appeared but without the re-emergence of Lgr5-positive CBC cells, which were eventually depleted by four months following induction. These findings indicate that KLF5 plays an important role in regulating proliferation and survival of CBC stem cells in the intestine.
Keywords: intestinal epithelium, stem cell, Lgr5, Krüppel-like factors
The intestinal epithelium is divided into two compartments: the crypt and the villus. Intestinal stem cells (ISC) reside in the bottom of each crypt and give rise to daughter progenitor cells (also called transit amplifying or TA cells) that eventually populate all of the cells in the villus [1, 2]. Historically, cells located at position +4 from the bottom of the crypt [3], through DNA label retention experiments, were found to be slow-cycling or quiescent and thought to be the source of ISC [3, 4]. The +4 cell was later identified to express B lymphoma Mo-MLV insertion region 1 (Bmi1), a component of the polycomb repressor protein complex [5]. Subsequently, +4 cells are found to express several other markers including Hopx, Lrig1, mTert and Sox9 [6–9]. The Bmi1+ quiescent +4 stem cells are resistant to ionizing radiation and contribute to homeostatic regeneration post-irradiation [10–12].
Recently, a second pool of cells, called crypt base columnar (CBC) cells that are situated at the bottom of the intestinal crypt, was found to exhibit stem cell characteristics [13]. These cells express an orphan G protein-coupled receptor called Lgr5, which is part of the Wnt signaling pathway [13]. By employing sophisticated gene-targeting and lineage tracing approaches, Lgr5-expressing CBC cells were found to serve as the precursors to all cell lineages along the crypt-villus axis [13–15]. These observations provide evidence that the rapidly cycling CBC cells represent the pool of active ISC in the intestine.
Our laboratory has a longstanding interest in understanding the mechanisms by which a number of Krüppel-like factors (KLFs) regulate homeostasis of intestinal epithelial cells [16–18]. KLFs belong to a family of 17 transcription factors with homology to the Drosophila Krüppel gene product [19, 20]. KLFs are closely related to the Sp1 family of transcription factors in that they contain three highly conserved C2H2 Zn finger motifs at the carboxyl terminus [18, 20, 21]. The zinc fingers of KLFs bind to GC-rich or CACCC sequences in the promoters of many genes with which to exert their transcriptional effects [18, 22]. Amino acid sequences outside the zinc finger domains of KLFs are quite diverse and are involved in determining their transcription-regulatory activities [19]. Based on structure-function characteristics, KLFs are divided into 3 groups: Group 1 (KLFs 3, 8 and 12), which is predominantly transcriptional repressors; Group 2 (KLFs 1, 2, 4, 5, 6, and 7); which are predominantly transcriptional activators; and Group 3 (KLFs 9, 10, 11, 13, 14, and 16), which are also transcriptional repressors by interacting with Sin3A. KLFs 15 and 17 are grouped separately [20]. KLFs are expressed in diverse mammalian tissues and regulate fundamentally important biological processes such as adipogenesis [23, 24], proliferation [16], differentiation [25], cancer [26–29], inflammation [30], and apoptosis [31–34]. Among them, KLF4 and KLF5 are differentially expressed in the adult intestinal epithelium and are involved in maintaining epithelial homeostasis [16, 17].
KLF4, also called gut-enriched Krüppel-like factor or GKLF, was initially found to be expressed in the intestine [35] and subsequently in epithelial cells of the skin, therefore also named epithelial zinc finger (EZF) [36]. In the intestine, KLF4 is primarily expressed in the terminally differentiated cells of the intestinal epithelium, where it maintains a quiescent state by negatively regulating the cell cycle [35, 37]. Intestine-specific deletion of Klf4 in mice results in increased proliferation and altered differentiation [37]. KLF4 expression is also activated by agents causing DNA damage such as ionizing irradiation [33, 38, 39] and a recent study indicates that KLF4 is a radio-protective factor for the intestine following ionizing radiation-induced gut injury [34]. These findings point to an important role of KLF4 in maintaining intestinal epithelial homeostasis.
In addition to KLF4, KLF5 is known by its abundant expression in the intestinal epithelium and was initially called intestinal Krüppel-like factor or IKLF [40]. It was later found to be present in many other tissues including other epithelial cells as well as adipocytes, neuronal cells, leukocytes, and vascular smooth muscle cells [41]. KLF5 has important functions during development as its homozygous deletion from mice results in embryonic lethality [42]. In the intestine, Klf5 in mice is primarily expressed in the actively proliferating cells of the intestinal crypts [17]. Mice with intestine-specific deletion of Klf5 (as directed by villin-Cre recombinase) die in the neonatal period due to failure of the intestine to develop [41]. Those with variegated deletion survived but suffered from stunted growth compared to their littermates with wild-type [41]. Further investigation into the intestine-specific function of Klf5 in adult mice led to the development of an inducible intestine-specific knockout mouse model. Here an estrogen-regulated Cre recombinase driven by the villin promoter is only expressed following treatment with the inducer, tamoxifen [43]. Mice were phenotypically normal in the absence of tamoxifen. Within 3 to 5 days after the administration of tamoxifen, there was a loss of proliferating cells in the intestine [44]. Transcriptome analysis after induction showed an increase in expression of genes in the regenerative pathway including Reg1A, Reg3G, Reg3B, as well as Sox9 [44]. Importantly, despite the initial loss of the proliferative response due to Klf5 deletion, there was a robust response to repair and replenish the epithelium later during the regenerative process [44]. The precise mechanism by which the regenerative response is mediated following Klf5 deletion remains to be determined.
Since KLF5 plays a crucial role in regulating proliferation of intestinal epithelial cells, we sought to determine whether it regulates ISC proliferation. A careful inspection shows that Klf5 is not only expressed in the TA cell population of the intestinal crypt but in CBC cells that express Lgr5 [45]. Using the inducible Cre recombinase driven by the Lgr5 promoter (Lgr5/EGFP-CreER), we deleted Klf5 in adult mice from CBC cells only. Intestinal tissues were sampled at various time points from 3 to 112 days following the initial administration of tamoxifen. During the early phase (between 3 and 11 days) of deletion, both CBC and TA cells in crypts that express the Lgr5/EGFP-CreER transgene (which has a variegated penetrance) were no longer proliferating [45]. This was accompanied by an increase in apoptosis in those crypts that express EGFP. By day 14 following the initial administration of tamoxifen, both Klf5 expression and proliferation were reestablished in the TA cells but not in the CBC cells that express EGFP [45]. Eventually by 112 days after the initial administration of tamoxifen, over 90% of intestinal crypts that express EGFP were lost [45]. These results suggest that in the absence of active proliferation, Lgr5-expressing CBC cells have an approximate half-life of 30 to 50 days in the intestine.
The ability of intestinal crypt to replenish itself with proliferating TA cells post-Klf5 deletion from Lgr5-expressing CBC cells is quite intriguing. Although we currently do not understand how this is accomplished, a number of possibilities exist: (1) stem cells migrated from adjacent crypts (where Klf5 is not deleted from CBC cells); (2) activation of resident quiescent stem cells (e.g. Bmi1-expressing LRC) following cessation of CBC cell division; or (3) in conjunction with the neutral-drift model for competing stem cells [46, 47]. Perhaps a model with a more robust expression of the Lgr5/Cre from which a more complete deletion of Klf5 can be accomplished would reveal the true physiological function of Klf5 in regulating ISC function.
During the course of our experiments, an independent study reported similar effects as ours upon deletion of Klf5 from Lgr5-positive CBC cells [48]. That study corroborated our findings but also demonstrated that Klf5 is an obligatory factor, necessary for the survival and transformation of intestinal epithelial cells [48]. The latter conclusion stemmed from the observation that Klf5 is crucial in mediating Wnt/β-catenin-driven intestinal tumorigenesis, a fact previously established by our group [28].
It is now a well-established fact that a high degree of plasticity occurs in ISC. Various cell populations as identified by different markers exhibit diverse behavior and function in various physiological or pathophysiological contexts. The series of studies from our group using gene knockout have shown that KLF5 plays a significant role in regulating proliferation of CBC ISC under homeostatic conditions and perhaps in the subsequent regenerative response following perturbation of ISC homeostasis. Further investigation into how KLF5 is involved in epithelial regeneration may shed additional light on the biochemical characteristics of ISC in pathological states.
Acknowledgments
NIH Grant Funding VWY (DK052230, DK093680, and CA084197)
Footnotes
Conflict of Interests
No conflict of interest for any authors.
References
- 1.Podolsky DK. Regulation of intestinal epithelial proliferation: a few answers, many questions. Am J Physiol. 1993;264:G179–186. doi: 10.1152/ajpgi.1993.264.2.G179. [DOI] [PubMed] [Google Scholar]
- 2.Booth D, Potten CS. Protection against mucosal injury by growth factors and cytokines. J Natl Cancer Inst Monogr. 2001:16–20. doi: 10.1093/oxfordjournals.jncimonographs.a003433. [DOI] [PubMed] [Google Scholar]
- 3.Potten CS, Kovacs L, Hamilton E. Continuous labelling studies on mouse skin and intestine. Cell Tissue Kinet. 1974;7:271–283. doi: 10.1111/j.1365-2184.1974.tb00907.x. [DOI] [PubMed] [Google Scholar]
- 4.Cheng H, Leblond CP. Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian Theory of the origin of the four epithelial cell types. Am J Anat. 1974;141:537–561. doi: 10.1002/aja.1001410407. [DOI] [PubMed] [Google Scholar]
- 5.Sangiorgi E, Capecchi MR. Bmi1 is expressed in vivo in intestinal stem cells. Nat Genet. 2008;40:915–920. doi: 10.1038/ng.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Powell AE, Wang Y, Li Y, Poulin EJ, Means AL, Washington MK, et al. The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor. Cell. 2012;149:146–158. doi: 10.1016/j.cell.2012.02.042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Formeister EJ, Sionas AL, Lorance DK, Barkley CL, Lee GH, Magness ST. Distinct SOX9 levels differentially mark stem/progenitor populations and enteroendocrine cells of the small intestine epithelium. Am J Physiol Gastrointest Liver Physiol. 2009;296:G1108–1118. doi: 10.1152/ajpgi.00004.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Takeda N, Jain R, LeBoeuf MR, Wang Q, Lu MM, Epstein JA. Interconversion between intestinal stem cell populations in distinct niches. Science. 2011;334:1420–1424. doi: 10.1126/science.1213214. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Montgomery RK, Carlone DL, Richmond CA, Farilla L, Kranendonk ME, Henderson DE, et al. Mouse telomerase reverse transcriptase (mTert) expression marks slowly cycling intestinal stem cells. Proc Natl Acad Sci U S A. 2011;108:179–184. doi: 10.1073/pnas.1013004108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Lopez-Arribillaga E, Rodilla V, Pellegrinet L, Guiu J, Iglesias M, Roman AC, et al. Bmi1 regulates murine intestinal stem cell proliferation and self-renewal downstream of Notch. Development. 2014;142:41–52. doi: 10.1242/dev.107714. [DOI] [PubMed] [Google Scholar]
- 11.Middendorp S, Schneeberger K, Wiegerinck CL, Mokry M, Akkerman RD, van Wijngaarden S, et al. Adult stem cells in the small intestine are intrinsically programmed with their location-specific function. Stem Cells. 2014;32:1083–1091. doi: 10.1002/stem.1655. [DOI] [PubMed] [Google Scholar]
- 12.Yan KS, Chia LA, Li X, Ootani A, Su J, Lee JY, et al. The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations. Proc Natl Acad Sci U S A. 2012;109:466–471. doi: 10.1073/pnas.1118857109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2007;449:1003–1007. doi: 10.1038/nature06196. [DOI] [PubMed] [Google Scholar]
- 14.Clevers HC, Bevins CL. Paneth cells: maestros of the small intestinal crypts. Annu Rev Physiol. 2013;75:289–311. doi: 10.1146/annurev-physiol-030212-183744. [DOI] [PubMed] [Google Scholar]
- 15.Barker N, van Oudenaarden A, Clevers H. Identifying the stem cell of the intestinal crypt: strategies and pitfalls. Cell Stem Cell. 2012;11:452–460. doi: 10.1016/j.stem.2012.09.009. [DOI] [PubMed] [Google Scholar]
- 16.Ghaleb AM, Nandan MO, Chanchevalap S, Dalton WB, Hisamuddin IM, Yang VW. Kruppel-like factors 4 and 5: the yin and yang regulators of cellular proliferation. Cell Res. 2005;15:92–96. doi: 10.1038/sj.cr.7290271. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.McConnell BB, Ghaleb AM, Nandan MO, Yang VW. The diverse functions of Kruppel-like factors 4 and 5 in epithelial biology and pathobiology. Bioessays. 2007;29:549–557. doi: 10.1002/bies.20581. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Philipsen S, Suske G. A tale of three fingers: the family of mammalian Sp/XKLF transcription factors. Nucleic Acids Res. 1999;27:2991–3000. doi: 10.1093/nar/27.15.2991. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.McConnell BB, Yang VW. Mammalian Kruppel-like factors in health and diseases. Physiol Rev. 2010;90:1337–1381. doi: 10.1152/physrev.00058.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Kaczynski J, Cook T, Urrutia R. Sp1- and Kruppel-like transcription factors. Genome Biol. 2003;4:206. doi: 10.1186/gb-2003-4-2-206. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Kadonaga JT, Carner KR, Masiarz FR, Tjian R. Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell. 1987;51:1079–1090. doi: 10.1016/0092-8674(87)90594-0. [DOI] [PubMed] [Google Scholar]
- 22.Miller IJ, Bieker JJ. A novel, erythroid cell-specific murine transcription factor that binds to the CACCC element and is related to the Kruppel family of nuclear proteins. Mol Cell Biol. 1993;13:2776–2786. doi: 10.1128/mcb.13.5.2776. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Rosen ED, Spiegelman BM. Molecular regulation of adipogenesis. Annu Rev Cell Dev Biol. 2000;16:145–171. doi: 10.1146/annurev.cellbio.16.1.145. [DOI] [PubMed] [Google Scholar]
- 24.Wu Z, Wang S. Role of kruppel-like transcription factors in adipogenesis. Dev Biol. 2013;373:235–243. doi: 10.1016/j.ydbio.2012.10.031. [DOI] [PubMed] [Google Scholar]
- 25.Oishi Y, Manabe I, Tobe K, Tsushima K, Shindo T, Fujiu K, et al. Kruppel-like transcription factor KLF5 is a key regulator of adipocyte differentiation. Cell Metab. 2005;1:27–39. doi: 10.1016/j.cmet.2004.11.005. [DOI] [PubMed] [Google Scholar]
- 26.Ghaleb AM, Yang VW. The Pathobiology of Kruppel-like Factors in Colorectal Cancer. Curr Colorectal Cancer Rep. 2008;4:59–64. doi: 10.1007/s11888-008-0011-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Ghaleb AM, McConnell BB, Nandan MO, Katz JP, Kaestner KH, Yang VW. Haploinsufficiency of Kruppel-like factor 4 promotes adenomatous polyposis coli dependent intestinal tumorigenesis. Cancer Res. 2007;67:7147–7154. doi: 10.1158/0008-5472.CAN-07-1302. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.McConnell BB, Bialkowska AB, Nandan MO, Ghaleb AM, Gordon FJ, Yang VW. Haploinsufficiency of Kruppel-like factor 5 rescues the tumor-initiating effect of the Apc(Min) mutation in the intestine. Cancer Res. 2009;69:4125–4133. doi: 10.1158/0008-5472.CAN-08-4402. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Tetreault MP, Yang Y, Katz JP. Kruppel-like factors in cancer. Nat Rev Cancer. 2013;13:701–713. doi: 10.1038/nrc3582. [DOI] [PubMed] [Google Scholar]
- 30.Ghaleb AM, Laroui H, Merlin D, Yang VW. Genetic deletion of Klf4 in the mouse intestinal epithelium ameliorates dextran sodium sulfate-induced colitis by modulating the NF-kappaB pathway inflammatory response. Inflamm Bowel Dis. 2014;20:811–820. doi: 10.1097/MIB.0000000000000022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Rowland BD, Bernards R, Peeper DS. The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene. Nat Cell Biol. 2005;7:1074–1082. doi: 10.1038/ncb1314. [DOI] [PubMed] [Google Scholar]
- 32.Rowland BD, Peeper DS. KLF4, p21 and context-dependent opposing forces in cancer. Nat Rev Cancer. 2006;6:11–23. doi: 10.1038/nrc1780. [DOI] [PubMed] [Google Scholar]
- 33.Ghaleb AM, Katz JP, Kaestner KH, Du JX, Yang VW. Kruppel-like factor 4 exhibits antiapoptotic activity following gamma-radiation-induced DNA damage. Oncogene. 2007;26:2365–2373. doi: 10.1038/sj.onc.1210022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Talmasov D, Xinjun Z, Yu B, Nandan MO, Bialkowska AB, Elkarim E, et al. Kruppel-like factor 4 is a radioprotective factor for the intestine following gamma-radiation-induced gut injury in mice. Am J Physiol Gastrointest Liver Physiol. 2015;308:G121–138. doi: 10.1152/ajpgi.00080.2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Shields JM, Christy RJ, Yang VW. Identification and characterization of a gene encoding a gut-enriched Kruppel-like factor expressed during growth arrest. J Biol Chem. 1996;271:20009–20017. doi: 10.1074/jbc.271.33.20009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Yet SF, McA’Nulty MM, Folta SC, Yen HW, Yoshizumi M, Hsieh CM, et al. Human EZF, a Kruppel-like zinc finger protein, is expressed in vascular endothelial cells and contains transcriptional activation and repression domains. J Biol Chem. 1998;273:1026–1031. doi: 10.1074/jbc.273.2.1026. [DOI] [PubMed] [Google Scholar]
- 37.Ghaleb AM, McConnell BB, Kaestner KH, Yang VW. Altered intestinal epithelial homeostasis in mice with intestine-specific deletion of the Kruppel-like factor 4 gene. Dev Biol. 2011;349:310–320. doi: 10.1016/j.ydbio.2010.11.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Yoon HS, Chen X, Yang VW. Kruppel-like factor 4 mediates p53-dependent G1/S cell cycle arrest in response to DNA damage. J Biol Chem. 2003;278:2101–2105. doi: 10.1074/jbc.M211027200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Yoon HS, Yang VW. Requirement of Kruppel-like factor 4 in preventing entry into mitosis following DNA damage. J Biol Chem. 2004;279:5035–5041. doi: 10.1074/jbc.M307631200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Conkright MD, Wani MA, Anderson KP, Lingrel JB. A gene encoding an intestinal-enriched member of the Kruppel-like factor family expressed in intestinal epithelial cells. Nucleic Acids Res. 1999;27:1263–1270. doi: 10.1093/nar/27.5.1263. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.McConnell BB, Kim SS, Yu K, Ghaleb AM, Takeda N, Manabe I, et al. Kruppel-like factor 5 is important for maintenance of crypt architecture and barrier function in mouse intestine. Gastroenterology. 2011;141:1302–1313. doi: 10.1053/j.gastro.2011.06.086. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Shindo T, Manabe I, Fukushima Y, Tobe K, Aizawa K, Miyamoto S, et al. Kruppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling. Nat Med. 2002;8:856–863. doi: 10.1038/nm738. [DOI] [PubMed] [Google Scholar]
- 43.el Marjou F, Janssen KP, Chang BH, Li M, Hindie V, Chan L, et al. Tissue-specific and inducible Cre-mediated recombination in the gut epithelium. Genesis. 2004;39:186–193. doi: 10.1002/gene.20042. [DOI] [PubMed] [Google Scholar]
- 44.Nandan MO, Ghaleb AM, Liu Y, Bialkowska AB, McConnell BB, Shroyer KR, et al. Inducible intestine-specific deletion of Kruppel-like factor 5 is characterized by a regenerative response in adult mouse colon. Dev Biol. 2014;387:191–202. doi: 10.1016/j.ydbio.2014.01.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Nandan MO, Ghaleb AM, Bialkowska AB, Yang VW. Kruppel-like factor 5 is essential for proliferation and survival of mouse intestinal epithelial stem cells. Stem Cell Res. 2015;14:10–19. doi: 10.1016/j.scr.2014.10.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Snippert HJ, van der Flier LG, Sato T, van Es JH, van den Born M, Kroon-Veenboer C, et al. Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells. Cell. 2010;143:134–144. doi: 10.1016/j.cell.2010.09.016. [DOI] [PubMed] [Google Scholar]
- 47.Lopez-Garcia C, Klein AM, Simons BD, Winton DJ. Intestinal stem cell replacement follows a pattern of neutral drift. Science. 2010;330:822–825. doi: 10.1126/science.1196236. [DOI] [PubMed] [Google Scholar]
- 48.Nakaya T, Ogawa S, Manabe I, Tanaka M, Sanada M, Sato T, et al. KLF5 regulates the integrity and oncogenicity of intestinal stem cells. Cancer Res. 2014;74:2882–2891. doi: 10.1158/0008-5472.CAN-13-2574. [DOI] [PubMed] [Google Scholar]